RCE.AX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 03:00):

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic antiinfectives in Australia, the United States, and the United Kingdom...

Stats
Dagens volum	24 567.00
Gjennomsnittsvolum	170 672
Markedsverdi	132.57M
EPS	$0 ( 2024-02-25 )
Neste inntjeningsdato	( $0 ) 2024-07-29
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.83
ATR14	$0.00500 (0.78%)

Recce Pharmaceuticals Ltd Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Recce Pharmaceuticals Ltd Økonomi

Annual	2023
Omsetning:	$4.37M
Bruttogevinst:	$4.15M (95.03 %)
EPS:	$-0.0744

FY	2023
Omsetning:	$4.37M
Bruttogevinst:	$4.15M (95.03 %)
EPS:	$-0.0744

FY	2022
Omsetning:	$3.08M
Bruttogevinst:	$2.90M (93.92 %)
EPS:	$-0.0625

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.143

Financial Reports:

No articles found.

Recce Pharmaceuticals Ltd

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic antiinfectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.